Company Profiles

driven by the PitchBook Platform

Orphazyme

Description

Developer of therapeutics for rare and genetic disorders. The company develops therapeutics for the treatment of lysosomal storage diseases, a group of rare genetic disorders that result from deficiencies of lysosomal enzymes or other lysosomal components.

2009

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$23.3M

Latest Deal Amount

$51M

Total Amount Raised

Description

Developer of therapeutics for rare and genetic disorders. The company develops therapeutics for the treatment of lysosomal storage diseases, a group of rare genetic disorders that result from deficiencies of lysosomal enzymes or other lysosomal components.

Website:

www.orphazyme.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals
Therapeutic Devices

Primary Office

Ole Maaløes Vej 3 2200 CopenhagenDenmark +45 7070 2980
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Orphazyme's full profile, request a free trial.

Orphazyme Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Orphazyme Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Aescap VentureVenture CapitalMinority000 0000000 0000
IDInvest PartnersVenture CapitalMinority000 0000000 0000
Kurma PartnersVenture CapitalMinority000 0000000 0000
NovoCorporate Venture CapitalMinority000 0000000 0000
Sunstone CapitalVenture CapitalMinority000 0000000 0000
Aescap Venture Venture Capital
IDInvest Partners Venture Capital
Kurma Partners Venture Capital
Novo Corporate Venture Capital
Sunstone Capital Venture Capital

Orphazyme Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Anders Mørkeberg Hinsby Ph.DCo-Founder & Chief Executive Officer
Thomas Kirkegaard Jensen Ph.DCo-Founder & Chief Scientific Officer
Soren Neve Ph.DDirector of pharmacology
Signe Humle Jorgensen Ph.DDirector of Pharmacology
Martin KornumCo-Founder, Director of IPR and Board Member
Anders Mørkeberg Hinsby Ph.D Co-Founder & Chief Executive Officer
Thomas Kirkegaard Jensen Ph.D Co-Founder & Chief Scientific Officer
Soren Neve Ph.D Director of pharmacology
Signe Humle Jorgensen Ph.D Director of Pharmacology
Martin Kornum Co-Founder, Director of IPR and Board Member

Orphazyme Board Members (9)

NameRepresentingRoleSinceContact
Info
Bo Jesper Hansen Ph.DSelfBoard Member000 0000
Georges Gemayel Ph.DSelfChairman000 0000
Kim Dueholm Ph.DNovoBoard Member000 0000
Martin Bonde Ph.DSelfBoard Member000 0000
Martin KornumOrphazymeCo-Founder, Director of IPR and Board Member000 0000
Bo Jesper Hansen Ph.D Board Member Self
Georges Gemayel Ph.D Chairman Self
Kim Dueholm Ph.D Board Member Novo
Martin Bonde Ph.D Board Member Self
Martin Kornum Co-Founder, Director of IPR and Board Member Orphazyme
Request full access to PitchBook